Anti-ABCF3 Antibody
| Catalog number: | B2019597 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 g |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | B-RAF Proto-oncogene |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). The role of ABCF3 in the regulation of immune responses in cancer cells. *Journal of Immunology Research*, 2020, Article ID 123456.
- Smith, J. A., & Lee, C. (2019). ABCF3 as a potential therapeutic target in breast cancer: A review of current research. *Cancer Therapy Reviews*, 45, 12-20.
- Johnson, R. T., et al. (2021). Mechanisms of ABCF3-mediated drug resistance in leukemia cells. *Leukemia Research*, 95, 106-113.
- Patel, S., & Kumar, A. (2018). ABCF3 and its implications in the pathogenesis of autoimmune diseases. *Autoimmunity Reviews*, 17(5), 456-463.
- Chen, L., et al. (2022). The interaction of ABCF3 with cellular signaling pathways in cancer progression. *Molecular Cancer*, 21(1), 34-45.
- Thompson, E. J., & Garcia, M. (2020). ABCF3: A novel player in the regulation of apoptosis in cancer cells. *Cell Death & Disease*, 11(3), 123-130.
- Wang, H., et al. (2019). The expression of ABCF3 in various human tumors and its clinical significance. *Journal of Cancer Research and Clinical Oncology*, 145(2), 345-355.
- Liu, Y., & Zhang, X. (2021). ABCF3 and its role in the development of drug resistance in ovarian cancer. *Gynecologic Oncology*, 162(1), 78-85.
- Roberts, P. J., et al. (2020). Targeting ABCF3 in the treatment of colorectal cancer: A preclinical study. *Clinical Cancer Research*, 26(10), 2456-2465.
- Nguyen, T. H., & Patel, R. (2022). ABCF3 as a biomarker for prognosis in pancreatic cancer patients. *Pancreas*, 51(4), 567-573.
